연구성과로 돌아가기
2024 연구성과별 연구자 정보 (1680 / 2344)
※ 현재 Web of Science 저자 정보만 집계되어 있습니다.
※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
| Document Title | Author Full Name | Author Short Name | Index | Corresponding | Address | ResearcherID | ResearcherID Author Name | ORCID | ORCID Author Name | Related Email |
|---|---|---|---|---|---|---|---|---|---|---|
| Population pharmacokinetic model of rifampicin for personalized tuberculosis pharmacotherapy: Effects of SLCO1B1 polymorphisms on drug exposure | Anh, Nguyen Ky | Anh, NK | 11 | Inje Univ, Dept Pharmacol, Coll Med, Pusan, South Korea | KBP-7253-2024 | Nguyen Ky, Anh | 0000-0001-9513-9563 | Nguyen Ky, Anh | ysncho@gmail.com;phshinjg@inje.ac.kr; | |
| Population pharmacokinetic model of rifampicin for personalized tuberculosis pharmacotherapy: Effects of SLCO1B1 polymorphisms on drug exposure | Anh, Nguyen Ky | Anh, NK | 11 | Inje Univ, PharmacoGen Res Ctr, Coll Med, Pusan, South Korea | KBP-7253-2024 | Nguyen Ky, Anh | 0000-0001-9513-9563 | Nguyen Ky, Anh | ysncho@gmail.com;phshinjg@inje.ac.kr; | |
| Population pharmacokinetic model of rifampicin for personalized tuberculosis pharmacotherapy: Effects of SLCO1B1 polymorphisms on drug exposure | Ahn, Sangzin | Ahn, S | 12 | Inje Univ, Ctr Personalized Precis Med TB, Coll Med, Pusan, South Korea | ysncho@gmail.com;phshinjg@inje.ac.kr; | |||||
| Population pharmacokinetic model of rifampicin for personalized tuberculosis pharmacotherapy: Effects of SLCO1B1 polymorphisms on drug exposure | Ahn, Sangzin | Ahn, S | 12 | Inje Univ, Dept Pharmacol, Coll Med, Pusan, South Korea | ysncho@gmail.com;phshinjg@inje.ac.kr; | |||||
| Population pharmacokinetic model of rifampicin for personalized tuberculosis pharmacotherapy: Effects of SLCO1B1 polymorphisms on drug exposure | Ahn, Sangzin | Ahn, S | 12 | Inje Univ, PharmacoGen Res Ctr, Coll Med, Pusan, South Korea | ysncho@gmail.com;phshinjg@inje.ac.kr; | |||||
| Population pharmacokinetic model of rifampicin for personalized tuberculosis pharmacotherapy: Effects of SLCO1B1 polymorphisms on drug exposure | Long, Nguyen Phuoc | Long, NP | 13 | Inje Univ, Ctr Personalized Precis Med TB, Coll Med, Pusan, South Korea | U-4162-2019 | Long, Nguyen Phuoc | ysncho@gmail.com;phshinjg@inje.ac.kr; | |||
| Population pharmacokinetic model of rifampicin for personalized tuberculosis pharmacotherapy: Effects of SLCO1B1 polymorphisms on drug exposure | Long, Nguyen Phuoc | Long, NP | 13 | Inje Univ, Dept Pharmacol, Coll Med, Pusan, South Korea | U-4162-2019 | Long, Nguyen Phuoc | ysncho@gmail.com;phshinjg@inje.ac.kr; | |||
| Population pharmacokinetic model of rifampicin for personalized tuberculosis pharmacotherapy: Effects of SLCO1B1 polymorphisms on drug exposure | Long, Nguyen Phuoc | Long, NP | 13 | Inje Univ, PharmacoGen Res Ctr, Coll Med, Pusan, South Korea | U-4162-2019 | Long, Nguyen Phuoc | ysncho@gmail.com;phshinjg@inje.ac.kr; | |||
| Population pharmacokinetic model of rifampicin for personalized tuberculosis pharmacotherapy: Effects of SLCO1B1 polymorphisms on drug exposure | Cho, Yong-Soon | Cho, YS | 14 | 교신저자 | Inje Univ, Ctr Personalized Precis Med TB, Coll Med, Pusan, South Korea | ysncho@gmail.com;phshinjg@inje.ac.kr; | ||||
| Population pharmacokinetic model of rifampicin for personalized tuberculosis pharmacotherapy: Effects of SLCO1B1 polymorphisms on drug exposure | Cho, Yong-Soon | Cho, YS | 14 | 교신저자 | Inje Univ, Dept Pharmacol, Coll Med, Pusan, South Korea | ysncho@gmail.com;phshinjg@inje.ac.kr; | ||||
| Population pharmacokinetic model of rifampicin for personalized tuberculosis pharmacotherapy: Effects of SLCO1B1 polymorphisms on drug exposure | Cho, Yong-Soon | Cho, YS | 14 | 교신저자 | Inje Univ, PharmacoGen Res Ctr, Coll Med, Pusan, South Korea | ysncho@gmail.com;phshinjg@inje.ac.kr; | ||||
| Population pharmacokinetic model of rifampicin for personalized tuberculosis pharmacotherapy: Effects of SLCO1B1 polymorphisms on drug exposure | Cho, Yong-Soon | Cho, YS | 14 | 교신저자 | Inje Univ, Pharmaco Genom Res Ctr, Dept Pharmacol Clin Pharmacol, Coll Med, 72 Bokji Ro Busanjin Gu, Pusan 47392, South Korea | ysncho@gmail.com;phshinjg@inje.ac.kr; | ||||
| Population pharmacokinetic model of rifampicin for personalized tuberculosis pharmacotherapy: Effects of SLCO1B1 polymorphisms on drug exposure | Shin, Jae-Gook | Shin, JG | 15 | 교신저자 | Inje Univ, Ctr Personalized Precis Med TB, Coll Med, Pusan, South Korea | ysncho@gmail.com;phshinjg@inje.ac.kr; | ||||
| Population pharmacokinetic model of rifampicin for personalized tuberculosis pharmacotherapy: Effects of SLCO1B1 polymorphisms on drug exposure | Shin, Jae-Gook | Shin, JG | 15 | 교신저자 | Inje Univ, Dept Pharmacol, Coll Med, Pusan, South Korea | ysncho@gmail.com;phshinjg@inje.ac.kr; | ||||
| Population pharmacokinetic model of rifampicin for personalized tuberculosis pharmacotherapy: Effects of SLCO1B1 polymorphisms on drug exposure | Shin, Jae-Gook | Shin, JG | 15 | 교신저자 | Inje Univ, PharmacoGen Res Ctr, Coll Med, Pusan, South Korea | ysncho@gmail.com;phshinjg@inje.ac.kr; |
페이지 이동: